Sarcoidosis revealed by a spinal cord lesion;Neurosarcoïdose médullaire révélatrice

Revue Neurologique

Volumn 160, Issue 4 I, 2004, Pages 452-455

  Peltier, J ^a   Bugnicourt, J M ^a   Toussaint, P ^a   Rosa, A ^a   Godefroy, O ^a  

^a AMIENS UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; CORTICOSTEROID; DIPEPTIDYL CARBOXYPEPTIDASE; METHYLPREDNISOLONE SODIUM SUCCINATE; PREDNISONE ACETATE;

ADULT; AFRICA; ARTICLE; CASE REPORT; CEREBROSPINAL FLUID ANALYSIS; ENZYME BLOOD LEVEL; FEMALE; HUMAN; IMAGE ENHANCEMENT; LUNG LAVAGE; LYMPHADENOPATHY; LYMPHOCYTE COUNT; MEDIASTINUM LYMPH NODE; MENINGITIS; MULTIPLE SCLEROSIS; NEGRO; NEUROIMAGING; NEURORADIOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; PARAMETER; RACE; RELAPSE; SARCOIDOSIS; SPINAL CORD BIOPSY; SPINAL CORD COMPRESSION; SPINAL CORD LESION; SPINAL NERVE; THORAX RADIOGRAPHY; TREATMENT OUTCOME;

EID: 2342535174     PISSN: 00353787     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0035-3787(04)70928-5     Document Type: Article

References (20)

1. ASKANASY C. (1952). Sarcoidosis of the Central Nervous System. J Neuropathol Exp Neurol, 11: 392-400.
2. BOGOUSSLOWSKY J, HUNGERBÜHLER JP, REGLY F, GRAF HJ. (1982). Subacute myelopathy as the presentation of neurosarcoidosis. Acta Neurochir, 65:193-97.
3. CACOUB P, SBAÏ A, HAUSFATER P et al. (2000). Sarcoïdose systémique révélée par une localisation médullaire. Rev Neurol (Paris), 15:6 896-900.
4. CHAPELON C, UZZAN B, PIETTE JC et al. (1984). La sarcoïdose en médecine interne. Ann Med Interne, 135: 125-131.
5. CHAPELON C, ZIZA JM, PIETTE JC et al. (1990). Neurosarcoidosis: signs, course and treatment in 35 confirmed cases. Medicine, 69: 261-276.
6. CHRETIEN J, SALTIEL JC, STANISLAS-LEGUERN G. (1982). Sarcoïdose, In: Maladies dites systémiques, Kahn MF., Peltier AP., Ch 29, pp 630-649, Flammarion Médecine-Sciences édit., Paris.
7. CHRISTOFORIDIS GA, SPICKLER EM, RECIO MV, METHA BM (1999). MR of CNS sarcoidosis: correlation of imaging features to clinical symptoms and response to treatment. AJNR, 20: 655-669.
8. Th edition, Ch 292, pp: 1679-1684. McGraw-Hill, Inc NY.
9. DALE JC, O'BRIEN JF. (1999). Determination of angiotensin-converting enzyme levels in cerebrospinal fluid is not a useful test for the diagnosis of neurosarcoidosis. Mayo Clin Proc, 74: 535.
10. FERRIBY D, DE SEZE J, STOJKOVIC T et al. (2000). Manifestations cliniques et approche thérapeutique de la neurosarcoïdose: 40 cas. Rev Neurol (Paris), 156: 965-975.
11. GARCIN R. (1962). Sarcoïdose de la moelle lombo-sacrée. Askanasi (1952) et Jefferson (1957) cités par Garcin (1962). Acta Med Belg: 301-09.
12. JABS DA, JOHN C. (1986) Ocular involvment in chronic sarcoidosis. Ophthalmalogy, 102: 297-301.
13. JASTER JH, DOHAN FC, BERTORINI TE et al. (1997). Solitary spinal cord sarcoidosis without other manifestation of systemic sarcoidosis. Clinical Imaging, 21: 17-22.
14. JEFFERSON M. (1957). Sarcoidosis of the Nervous System. Brain, 80: 540-556.
15. JUNGER SS, STERN BJ, LEVINE SR, SIPOS E, MARTI-MASSO JF. (1993). Intramedullary spinal sarcoidosis. Clinical and magnetic resonance imaging characteristics. Neurology, 43: 333-337.
16. MATHEWS WB. (1986). Neurologic manifestations of sarcoidosis. In: Disease of the nervous system, Clinical biology, tome II, Ch 129, pp 1563-70. Asburey, Mc Khann, Mc Donald edit, WB Saunders Cie, Philadelphia.
17. NOWAK DA, WIDENKA DC. (2001) Neurosarcoidosis: a review of its intracranial manifestation. J Neurol, 248: 363-372.
18. OKSANEN V, FYHNQUIST F, SOMER H, GRONHAGEN-RISKA C. (1985a). Angiotensin converting enzyme in cerebrospinal fluid: a new assay. Neurology, 35: 1220-1223.
19. OKSANEN V, FYHRQUIST F, GRONHAGEN-RISKA C, SOMER H. (1985b). CSF angiotensin converting enzyme in neurosarcoidosis. Lancet, 1: 1050-1051.
20. OKSANEN V. (1994). Neurosarcoidosis. Sarcoidosis and other granulomatous disorders. Acta Neurol Scand: 285-309.